Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ News / India/  AIIMS Delhi to start second dose trial of Covaxin on 2-6 years by next week
BackBack

AIIMS Delhi to start second dose trial of Covaxin on 2-6 years by next week

The second dose of Covaxin has already been given to children aged between 6 to 12 years at Delhi's AIIMS, which is one of the centres for trials of the Covid-19 vaccine for those below 18 years

A health worker carries vials of the Covaxin vaccine against coronavirus at a health centre in New Delhi. (AFP)Premium
A health worker carries vials of the Covaxin vaccine against coronavirus at a health centre in New Delhi. (AFP)

All India Institute of Medical Sciences (AIIMS), New Delhi will start the second dose trial of Bharat Biotech's Covid-19 vaccine, Covaxin for children aged 2-6 years.

The second dose of Covaxin has already been given to children aged between 6 to 12 years at AIIMS, Delhi, which is one of the centres for trials of the vaccine for those below 18 years.

Trials for coronavirus vaccine for children are underway in the country ahead of an anticipated third wave of the pandemic. Earlier, Dr Randeep Guleria,AIIMS director, informed that the Covid-19 vaccine for children could likely be available in September.

Meanwhile, the government had earlier informed the Delhi High Court that Zydus Cadila has concluded the clinical trial of its DNA-based Covid-19 vaccine ZyCoV-D for the 12-18 age group and that it could soon be available.

In an affidavit dated 15 July, Satyendra Singh, Under Secretary to the Ministry of Health and Family Welfare, said, "It is submitted that Zydus Cadila which is developing a DNA vaccine has successfully concluded its clinical trial for the 12-18 age group."

Singh further said that Ahmedabad-based Zydus Cadila's DNA vaccine is "subject to the statutory permissions, the same may be available in the near future for children of the 12-18 age group ".

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

ABOUT THE AUTHOR
Meghna Sen
Business journalist tracking markets, companies, economy and crypto for Livemint. She has 6 years of experience with online and print publications. Email: meghnasen08@gmail.com
Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less
Published: 22 Jul 2021, 09:40 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App